Adicet Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Chen Schor, with a market cap of $65.8M.
Common questions about Adicet Bio, Inc.
Adicet Bio, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026.
Adicet Bio, Inc. has approximately 143 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.